Cognitive enhancing effects in young and old rats of pBC264, a selective CCK(B) receptor agonist

Psychopharmacology

Volumn 143, Issue 2, 1999, Pages 141-149

  Taghzouti, K ^c   Lena I ^b   Dellu, F ^a   Roques, B P ^b   Dauge V ^b   Simon, H ^a  

^a INSERM   (France)

^b Laboratoire de Pharmacochimie   (France)

^c FACULTÉ DES SCIENCES   (Morocco)

Author keywords

Ageing; BC264; CCK(B) receptor; Cholecystokinin; Memory; Rat

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT;

AGING; ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INDICATION; DRUG SCREENING; INFORMATION PROCESSING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; BENZODIAZEPINONES; CHOLECYSTOKININ; COGNITION; MALE; MAZE LEARNING; MEMORY; PEPTIDE FRAGMENTS; PHENYLUREA COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; STIMULATION, CHEMICAL;

EID: 0345315206     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050929     Document Type: Article

References (55)

1. Bradwejn J, Koszycki D, Couëtoux du Tertre, van Megen H, Den Boer J, Westenberg H, Annable L (1994) The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist in patients with panic disorder. Arch Gen Psychiatry 51:486-493
2. 125I) D-Tyr (Nle 28,31)-CCK 25-33 S. Eur J Neurosci 4:563-573
3. Charpentier B, Durieux C, Pelaprat D, Dor A, Reibaud M, Blanchard JC, Roques BP (1988) Enzyme-resistant CCK analogs with high affinities for central receptors. Peptides 9:835-841
4. Conrad CD, Galea LA, Kuroda Y, McEwen BS (1997) Chronic stress impairs rats spatial memory on the Y maze, and its effect is blocked by tianeptine pretreatment. Behav Neurosci 110:1321-1334
5. Crawley JN, Corwin R (1994) Biological actions of cholecystokinin. A review. Peptides 15:731-755
6. Crawley JN, Stivers JA, Blumstein LK, Paul SM (1985) Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence. J Neurosci 5:1972-1983
7. 264. Synapse 6:73-80
8. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H (1992) A two-trial memory task with automated recording: study in young and aged rats. Brain Res 588:132-139
9. Dellu F, Fauchey V, Le Moal M, Simon H (1997) Extension of a new-trial memory task in the rat: influence of environmental context on recognition processes. Neurobiol Learn Mem 67:112-120
10. 264, impairs socially reinforced memory in the three-panel runway test in rats. Behav Brain Res 65:139-146
11. Derrien M, McCort-Tranchepain I, Ducos B, Roques BP, Durieux C (1994b) Heterogeneity of CCK-B involved in animal models of anxiety. Pharmacol Biochem Behav 49:133-141
12. Durieux C, Coppey M, Zajac JM, Roques BP (1986) Occurrence of two cholecystokinin binding sites in guinea pig cortex. Biochem Biophys Res Commun 137:1167-1173
13. 264, first highly potent and very selective radioligand for CCK-B receptors. Eur J Pharmacol 168:269-270
14. Eigyo M, Katsuura G, Shintaku H, Shinohara S, Katoh A, Shomi T, Matsushita A (1992) Systemic administration of a cholecystokinin analogue, ceruletide, protects against ischemia-induced neurodegeneration in gerbils. Eur J Pharmacol 214:149-158
15. Fekete M, Lengyel A, Hegedüs B, Penke B, Zarandy M, Toth GK, Telegdy G (1984) Further analysis of the effects of cholecystokinin octapeptide on avoidance behavior in rats. Eur J Pharmacol 98:79-91
16. 3H] pentagastrin. Peptides 4:755-762
17. Greenstein RJ, Ybanez MM, Zhang RL, Bauman WA (1991) Is aging preprogrammed? Observations from the brain/gut axis. Mech Ageing Dev 61:113-121
18. Harper EA, Roberts SP, Shankley NP, Black W (1996) Analysis of variation in L-365,260 competition curves in radioligand binding assays. Br J Pharmacol 118:1717-1726
19. Harro J, Oreland L (1992) Age-related differences of cholecystokinin receptor binding in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 16:369-375
20. Harro J, Oreland L (1993) Cholecystokinin receptors and memory: a radial maze study. Pharmacol Biochem Behav 44: 509-517
21. Harro J, Vasar E (1991) Evidence that CCK-B receptor mediate the regulation of exploratory behavior in the rat. Eur J Pharmacol 193:473-477
22. Hill DR, Woodruff GN (1990) Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Res 526:276-283
23. Huang SC, Fortune KP, Wank SA, Kopin AS, Gardner JD (1994) Multiple affinity states of different cholecystokinin receptors. J Biol Chem 269:26121-21126
24. Itoh S, Lal H (1990) Influences of cholecystokinin and analogues on memory processes. Drug Dev Res 21:257-276
25. Itoh S, Takashima A, Maeda Y ( 1992) Memory impairment induced by peripherally administered cholecystokinin A-type receptor antagonists in rats. Drug Dev Res 26:89-99
26. Kessner RP, Bolland BL, Dakis M (1993) Memory for spatial locations, motor responses and objects : triple dissociation among the hippocampus, caudate nucleus, and extrastriate cortex. Exp Brain Res 93:462-470
27. Köhler S, Kapur S, Moscovitch M, Winocur G, Houle S (1995) Dissociation of pathways for object and spatial vision : a PET study in humans. Neuroreport 6:1865-1868
28. Koszycki D, Zachardko RM, Bradwejn J (1996) Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder. Psychiatry Res 62: 131-138
29. 264 increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats. Eur J Neurosci 9:1804-1814
30. Lemaire M, Piot O, Roques BP, Böhme GA, Blanchard JC (1992) Evidence for an endogenous cholecystokinin balance in social memory. NeuroReport 3:929-932
31. Lemaire M, Barneoud P, Böhme GA, Piot O, Haun F, Roques BP, Blanchard JC (1994a) CCK-A and CCK-B receptors enhance olfactory recognition via distinct neuronal pathways. Learn Mem 1:153-164
32. Lemaire M, Böhme GA, Piot O, Roques BP, Blanchard JC (1994b) CCK-A and CCK-B selective receptor agonists modulate olfactory recognition in male rats. Psychopharmacology 115:435-440
33. Léna I, Roques BP, Durieux C (1997) Dual modulation of dopamine release from anterior nucleus accumbens through cholescystokinin-B. J Neurochem 68:162-168
34. Lotti VJ, Chang RSL (1989) A new potent and selective non peptide gastrin antagonist and brain cholecystokumin receptor (CCKB) ligand: L 365, 260. Eur J Pharmacol 162:273-280
35. McDonald RJ, White N (1993) A triple dissociation of memory systems : hippocampus, amygdala and dorsal striatum. Behav Neurosci 107:3-22
36. Mazurek MF, Beal F (1991) Cholecystokinin and somatostatin in Alzheimer's disease post-mortem cerebral cortex. Neurology 41:716-719
37. Mercer LD, Beart PM, Horne MK, Finkelstein DI, Carrive P, Paxinos G (1996) On the distribution of cholecystokinin B receptors in monkey brain. Brain Res 738:313-318
38. Moran TH, Robinson PH, Goldrich MS, McHugues PR (1986) Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 362:175-179
39. Morley JE, Flood J, Silver AJ (1992) Effects of peripheral hormones on memory and ingestive behaviors. Psychoneuroendocrinology 17:391-399
40. Palmour RM, Bradwejn J, Ervin FR (1992) The anxiogenic effect of CCK-4 in monkeys are reduced by CCK-B antagonists, benzodiazepines or adenosine A2 agonist. Eur Neuropharmacol 2:193-195
41. Palmour RM, Durieux C, Roques BP (1993) Anxiogenic effects of CCK agonists in a non-human primates model: central or peripheral? CCK abstract. Chatham, Cape Cod, USA
42. 125I) Bolton-Hurter CCK8 Functional significance of subregional distribution. Eurochem Int 10:495-508
43. Perez DM, Hwa J, Gaivin R, Mathur M, Brown F, Graham RM (1996) Constitutive activation of a single effector pathway : evidence for multiple activation states of a G-protein-coupled receptor. J Pharmacol Exp Ther 49:112-122
44. Rex A, Barth L, Voigt JP, Domeney A, Fink H (1994) Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neurosci Lett 172:139-142
45. Ruiz-Gayo M, Delay-Goyet P, Durieux C, Corringer PJ, Baamonde A, Gacel J, Roques BP (1990) Investigation of opioid and cholecystokinin central receptors after peripheral injection of selective and enzyme-resistant peptides. J Control Release 13:147-155
46. 264 on rat sleep. Pharmacol Biochem Behav 38:545-548
47. Schreiber H, Stolz-Born G, Pietrowsky R, Kornhuber HH, Fehm HL, Born J (1995) Improved event-related potential signs of selective attention after administration of the cholecystokinin analog ceruletide in healthy persons. Biol Psychiatry 37:702-712
48. B antagonists: role of the nucleus accumbens. Peptides 17:593-599
49. Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN (1991) Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA 88:1130-1133
50. Skirboll LR, Grace AA, Hommer DW, Rehfeld J, Goldstein M, Hökfelt T, Bunney BS (1981) Peptide-monoamine oexistence: study of cholecystokinin-peptide action on midbrain dopamine neuron activity. Neuroscience 6:2111-2124
51. Takashima A, Itoh S (1989) Memory impairment induced by CCK-8 antagonists in passive avoidance response of the rats. Drug Dev Res 18:95-100
52. Ungerleider LG, Mishkin M (1992) Two cortical visual systems. In: Ingle DJ, Goodale MA, Mansfield RJW (eds) Analysis of visual behavior. MIT Press, Cambridge, Mass., pp 549-586
53. Wilson FAW, Scalaidhe SPO, Goldman-Rakic PS (1993) Dissociation of object and spatial processing domains in primate prefrontal cortex. Science 260:1955-1958
54. Woodruff GN, Hughes J (1991) Functional role of brain CCK receptors. Neuropeptides 19:45-56
55. B receptor activation protects CA1 neurons from ischemia-induced dysfunction in stroke-prone spontaneously hypertensive rat hippocampal slices. Neurosci Lett 191:99-102